In vitro circumvention of anthracycline-resistance in ehrlich ascites tumour by anthracycline analogues
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 39 (11) , 1721-1726
- https://doi.org/10.1016/0006-2952(90)90117-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Reduced variation in the clonogenic assay obtained by standardization of the cell culture conditions prior to drug testing on human small cell lung cancer cell linesInvestigational New Drugs, 1989
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Inter-experiment variation and dependence on culture conditions in assaying the chemosensitivity of human small cell lung cancer cell linesEuropean Journal of Cancer and Clinical Oncology, 1987
- Tumour cell resistance to anthracyclines ? A reviewCancer Chemotherapy and Pharmacology, 1985
- Membrane transport of anthracyclinesPharmacology & Therapeutics, 1982
- ACTIVE EFFLUX OF DAUNORUBICIN AND ADRIAMYCIN IN SENSITIVE AND RESISTANT SUBLINES OF P388-LEUKEMIA1979
- Active outward transport of daunomycin in resistant ehrlich ascites tumor cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973
- Antitumor activity of some derivatives of daunorubicin at the amino and methyl ketone functionsJournal of Medicinal Chemistry, 1972